Related content

Clinical Risk Management in Dutch Community Pharmacies: The Case of Drug-Drug Interactions

By Buurma Henk   De Smet Peter A.G.M   Egberts Antoine C.G.  

Drug Safety, Vol. 29, Iss. 8, 2006-01 ,pp. : 723-732

Adis International

Access to resources Recommend Favorite

Management of potential drug interactions in community pharmacies: a questionnaire-based survey in Switzerland

By Indermitte Jörg   Erba Laura   Beutler Marianne   Bruppacher Rudolf   Haefeli Walter   Hersberger Kurt  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 3, 2007-03 ,pp. : 297-305

Springer Publishing Company

Access to resources Recommend Favorite

Cardiovascular risk screening program in Australian community pharmacies

By Peterson Gregory  

Pharmacy World and Science, Vol. 32, Iss. 3, 2010-06 ,pp. : 373-380

Springer Publishing Company

Access to resources Recommend Favorite

Acceptance of a Chlamydia Screening Program in Community Pharmacies

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 37, Iss. 4, 2007-12 ,pp. : 287-291

John Wiley & Sons Inc

Access to resources Recommend Favorite

Laboratory Tests in the Clinical Risk Management of Potential Drug-Drug Interactions: A Cross-Sectional Study Using Drug-Dispensing Data from 100 Dutch Community Pharmacies

By Geerts Arjen F.J.   De Koning Fred H.P.   De Smet Peter A.G.M.   Van Solinge Wouter W.   Egberts Toine C.G.  

Drug Safety, Vol. 32, Iss. 12, 2009-12 ,pp. : 1189-1197

Adis International

Access to resources Recommend Favorite